Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
Open Access
- 15 April 1999
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 103 (8), 1169-1178
- https://doi.org/10.1172/jci5017
Abstract
Large neutral amino acids (LNAAs), including phenylalanine (Phe), compete for transport across the blood-brain barrier (BBB) via the L-type amino acid carrier. Accordingly, elevated plasma Phe impairs brain uptake of other LNAAs in patients with phenylketonuria (PKU). Direct effects of elevated brain Phe and depleted LNAAs are probably major causes for disturbed brain development and function in PKU. Competition for the carrier might conversely be put to use to lower Phe influx when the plasma concentrations of all other LNAAs are increased. This hypothesis was tested by measuring brain Phe in patients with PKU by quantitative 1H magnetic resonance spectroscopy during an oral Phe challenge with and without additional supplementation with all other LNAAs. Baseline plasma Phe was ∼1,000 μmol/l and brain Phe was ∼250 μmol/l in both series. Without LNAA supplementation, brain Phe increased to ∼400 μmol/l after the oral Phe load. Electroencephalogram (EEG) spectral analysis revealed acutely disturbed brain activity. With concurrent LNAA supplementation, Phe influx was completely blocked and there was no slowing of EEG activity. These results are relevant for further characterization of the LNAA carrier and of the pathophysiology underlying brain dysfunction in PKU and for treatment of patients with PKU, as brain function might be improved by continued LNAA supplementation.Keywords
This publication has 42 references indexed in Scilit:
- The Influence of Phenylalanine Intake on the Chemistry and Behaviour of a Phenylketonuric ChildActa Paediatrica, 2001
- A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic PhenotypeAmerican Journal of Human Genetics, 1998
- Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuriaThe Journal of Pediatrics, 1995
- Early-treated phenylketonuria: Adult neuropsychologic outcomeThe Journal of Pediatrics, 1994
- EEGs IN PHENYLKETONURIA I: FOLLOW‐UP TO ADULTHOOD; II: SHORT‐TERM DIET‐RELATED CHANGES IN EEGs AND COGNITIVE FUNCTIONDevelopmental Medicine and Child Neurology, 1993
- The role of the blood‐brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemiaJournal of Inherited Metabolic Disease, 1988
- Kinetic Constants for Blood—Brain Barrier Amino Acid Transport in Conscious RatsJournal of Neurochemistry, 1985
- Amino acid depletion in the blood and brain tissue of hyperphenylalaninemic rats is abolished by the administration of additional lysine: A contribution to the understanding of the metabolic defects in phenylketonuriaBiochemical Medicine, 1985
- Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseasesJournal of Inherited Metabolic Disease, 1982
- Standardized loading test with protein for the differentiation of phenylketonuria from hyperphenylalaninaemiaJournal of Inherited Metabolic Disease, 1982